Don’t Expect Abandonment Of US FDA User Fee Programs If They Sunset

peering over cliff
The prospect of a temporary lapse in authorization has stakeholders wondering what happens where the user fees end. • Source: Shutterstock

More from User Fees

More from Pathways & Standards